Conference
A phase II study of ZD6474, a vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in patients with relapsed multiple myeloma (MM).
Authors
Kovacs MJ; Reece DE; Marcellus D; Meyer RM; Matthews S; Dong RP; Eisenhauer E
Volume
104
Pagination
pp. 944A-944A
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 16, 2004
Name of conference
46th Annual Meeting of the American-Society-of-Hematology
Conference place
San Diego, CA
Conference start date
December 4, 2004
Conference end date
December 7, 2004
Conference proceedings
BLOOD
Issue
11
ISSN
0006-4971